REGISTERED
on 29 Oct 2024
Last Applicant/ Owned by
F-13009 Marseille
FR
Serial Number
79373552 filed on 12th Apr 2023
Registration Number
7546740 registered on 29th Oct 2024
Correspondent Address
Mitchell E. Radin
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
LONKIRLO
Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79373552
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 5375-0134
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 24th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 09th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 09th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 09th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th Feb 2024 | REFUSAL PROCESSED BY IB |